Other substances

IBIO-200

COVID-19 candidate vaccine

Phase of research

Potential treatment - theoretical effect

How it helps

Vaccine

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

IBIO-200 is a candidate vaccine being developed byiBio/CC-Pharming. It is a Subunit protein, plant produced type of candidate vaccine. It is based on the Protein Subunit platform. Currently, this COVID-19 candidate vaccine is in pre-clinical evaluation.

IBIO-200 on iBIO

 

 

Supporting references

Link Tested on Impact factor Notes Publication date
DRAFT landscape of COVID-19 candidate vaccines – 26 March 2020
in vitro Mar/26/2020
Export (.csv)